Smith & Nephew PLC reported Q2 2024 revenue of $1,441 million, up 5.6% from Q2 2023, with a half-year revenue of $2,827 million (up 4.3%). Key advancements include a trading profit increase of 12.8% and enhanced cash flow, with significant growth expected in US Hip and Knee Implants due to restructuring efforts begun in 2022.